DSKYF - AstraZeneca rises as oncology business drives Q1 beat
2024-04-25 08:37:36 ET
More on AstraZeneca
- AstraZeneca: What The Market's Missing
- What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals
- 5 Reasons AstraZeneca Stock Can Rise In 2024
- AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook
- AstraZeneca Q1 2024 Earnings Preview